Rein Therapeutics, Inc. Share Price
RNTXRein Therapeutics, Inc. Stock Performance
Open $1.53 | Prev. Close $1.56 | Circuit Range N/A |
Day Range $1.48 - $1.57 | Year Range $1.08 - $3.92 | Volume 5,815 |
Average Traded $1.54 |
Rein Therapeutics, Inc. Share Price Chart
About Rein Therapeutics, Inc.
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications; and LTI-05, an epithelial sodium channel for the treatment of cystic fibrosis. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. The company was incorporated in 2001 and is headquartered in Austin, Texas.
Rein Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.53 | $1.46 | +0.00% |
12-Nov-25 | $1.53 | $1.46 | -3.00% |
11-Nov-25 | $1.47 | $1.50 | -5.06% |
10-Nov-25 | $1.55 | $1.58 | -1.25% |
07-Nov-25 | $1.51 | $1.60 | +2.56% |
06-Nov-25 | $1.54 | $1.56 | -2.50% |
05-Nov-25 | $1.37 | $1.60 | +8.47% |
FAQs on Rein Therapeutics, Inc. Share Price
Can I buy Rein Therapeutics, Inc. shares in India?
What is the share price of Rein Therapeutics, Inc.?
What is the 5 year returns of Rein Therapeutics, Inc.?
What are the high & low stock price of Rein Therapeutics, Inc. today?
What is the 52-week high and low of Rein Therapeutics, Inc. stock?